Loading…
Aethlon Medical, Inc. is projected to rise to $0.8161 by 2027, a +22% move from its current price of $0.6668. AEMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.6269 | $0.6674 | $0.7104 | +0.08% |
| Aug 6 | $0.6114 | $0.6679 | $0.7296 | +0.17% |
| Aug 7 | $0.5999 | $0.6685 | $0.7449 | +0.25% |
| Aug 8 | $0.5904 | $0.669 | $0.7581 | +0.34% |
| Aug 9 | $0.5823 | $0.6696 | $0.77 | +0.42% |
| Aug 10 | $0.575 | $0.6702 | $0.781 | +0.50% |
| Aug 11 | $0.5685 | $0.6707 | $0.7913 | +0.59% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.5685 | $0.6707 | $0.7913 | +0.59% |
| Week 2 | $0.534 | $0.6747 | $0.8524 | +1.18% |
| Week 3 | $0.5096 | $0.6786 | $0.9037 | +1.78% |
| Week 4 | $0.4904 | $0.6826 | $0.9502 | +2.38% |
| Week 5 | $0.4744 | $0.6867 | $0.9938 | +2.98% |
| Week 6 | $0.4607 | $0.6907 | $1.04 | +3.58% |
| Week 7 | $0.4486 | $0.6948 | $1.08 | +4.19% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aethlon Medical, Inc. is a healthcare company that develops immunotherapeutic devices in the United States. It is described as a medical therapeutic company focused on novel immunotherapeutic technologies, including Hemopurifier, a clinical‑stage immunotherapeutic device intended to address unmet needs in oncology, life‑threatening infectious diseases, organ transplantation, and other disease states.
The company was founded in 1984 and is based in San Diego, California.
Aethlon Medical operates in the healthcare sector and is publicly listed under the symbol AEMD. Its activities and products are positioned within the medical therapeutic space in the United States, driven by development efforts in immunotherapeutic devices.
Aethlon Medical, Inc. (AEMD) is currently trading at $0.6628, reflecting a micro‑cap profile in the biotechnology/healthcare devices space. Its market capitalization is $1.75M and its market rank is 5454, highlighting a very small market presence in the broader market landscape.
The near‑term outlook is reflected in the 2026 forecast, where the avg price is $0.6628 with a min of $0.53 and a max of $0.9129, yielding a neutral sentiment and an ROI of 0. The forecast shows a path of modest upside potential in the coming years, with variability across annual periods.
Longer‑term projections extend to 2050, with a 2050 avg of $2.06 and a max of $4.73, implying a substantial potential up‑side and an ROI of 210.3% in that year’s projection. The forecast pattern includes years with bullish sentiment and higher average prices, alongside years with more conservative or flat expectations.
A major floor 20.5% below — a decisive break under it would weaken the trend.
The nearest floor, 20.5% below — buyers have tended to step in here.
The nearest ceiling, 183.4% above — a clean break opens room to run.
A major ceiling 360.4% above — clearing it would confirm fresh momentum.
Key AEMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AEMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.576 | Buy | $0.5968 | Buy |
| MA 10 | $0.586 | Buy | $0.6073 | Buy |
| MA 20 | $0.6425 | Buy | $0.7194 | Sell |
| MA 50 | $1.34 | Sell | $1.16 | Sell |
| MA 100 | $1.76 | Sell | $1.83 | Sell |
| MA 200 | $2.56 | Sell | $5.20 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.57 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 20.03 | Neutral |
| Williams %R (14) | -18.75 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | -4.35 | Sell |
| Bollinger %B (20,2) | 0.57 | Neutral |
| Stochastic %K (14) | 81.25 | Sell |
| TRIX (15) | -3.27 | Sell |
| Awesome (5,34) | -0.35 | Sell |
| Ultimate (7,14,28) | 55.03 | Neutral |
| Momentum (10) | 0.01 | Buy |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 0.57 | Buy |
| ADX (14) | 45.56 | Sell |
| ATR (14) | 0.05 | Info |
The 30‑day technical picture is NEUTRAL with RSI(14) at 40. The 50‑day simple moving average stands at $1.34 and the 200‑day simple moving average sits at $2.56, indicating a distance from longer‑term trend lines.
Support is listed at $0.53 and resistance at $1.89, framing a relatively tight near‑term range against the backdrop of a 30‑day price range from $0.439 to $1.00. The setup suggests limited near‑term momentum, consistent with the neutral sentiment.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.53 | $0.6668 | $0.9182 | 0% | Neutral | |
| $0.5947 | $0.8161 | $1.21 | +22% | Bullish | |
| $0.4778 | $0.6974 | $1.10 | +5% | Neutral | |
| $0.4021 | $0.6185 | $1.03 | -7% | Neutral | |
| $0.4114 | $0.6635 | $1.15 | 0% | Neutral | |
| $0.366 | $0.6171 | $1.11 | -7% | Neutral | |
| $0.4735 | $0.8328 | $1.54 | +25% | Bullish | |
| $0.5338 | $0.9777 | $1.86 | +47% | Bullish | |
| $0.4652 | $0.8864 | $1.73 | +33% | Bullish | |
| $0.4034 | $0.799 | $1.59 | +20% | Neutral | |
| $0.5218 | $1.16 | $2.54 | +74% | Bullish | |
| $0.9309 | $2.07 | $4.76 | +210% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.53 | $0.6668 | $0.792 | +0.00% |
| September 2026 | $0.5431 | $0.6601 | $0.8371 | -1.00% |
| October 2026 | $0.584 | $0.7198 | $0.9315 | +9.04% |
| November 2026 | $0.5762 | $0.7183 | $0.9447 | -0.21% |
| December 2026 | $0.5463 | $0.6882 | $0.9182 | -4.19% |
Click any year to see its month-by-month AEMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Aethlon Medical, Inc.'s 2026 outlook centres on $0.6668, within a $0.53 to $0.9182 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, AEMD could reach as high as $1.21, with a base case around $0.8161 and support toward $0.5947 — roughly +22% from $0.6668. Buyers look set to stay in control over this stretch.
Expect AEMD to range from $0.4778 to $1.10 through 2028. The $0.6974 average target implies a +5% move from current prices. That is -15% versus the projected 2027 average. Price action looks broadly range-bound.
The AEMD price prediction for 2029 points to an average of $0.6185 (low $0.4021, high $1.03) — a potential decline of -7% on today's $0.6668. A consolidation phase looks the most probable path here.
In 2030, AEMD is projected to trade between $0.4114 and $1.15, averaging $0.6635 — a potential decline of 0% from today's $0.6668. That is up +7% on the projected 2029 average. Price action looks broadly range-bound.
Aethlon Medical, Inc.'s 2031 outlook centres on $0.6171, within a $0.366 to $1.11 range. That is -7% versus the projected 2030 average. That marks a -7% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, AEMD could reach as high as $1.54, with a base case around $0.8328 and support toward $0.4735 — roughly +25% from $0.6668. Momentum favours further upside here.
Expect AEMD to range from $0.5338 to $1.86 through 2033. The $0.9777 average target implies a +47% move from current prices. That is up +17% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The AEMD price prediction for 2034 points to an average of $0.8864 (low $0.4652, high $1.73) — a potential gain of +33% on today's $0.6668. Momentum favours further upside here.
In 2035, AEMD is projected to trade between $0.4034 and $1.59, averaging $0.799 — a potential gain of +20% from today's $0.6668. That is -10% versus the projected 2034 average. A consolidation phase looks the most probable path here.
Aethlon Medical, Inc.'s 2040 outlook centres on $1.16, within a $0.5218 to $2.54 range. That is up +45% on the projected 2035 average. That marks a +74% change versus current levels. Momentum favours further upside here.
By 2050, AEMD could reach as high as $4.76, with a base case around $2.07 and support toward $0.9309 — roughly +210% from $0.6668. Buyers look set to stay in control over this stretch.
Investing $1,000 in AEMD today (≈ 1,499.70006 AEMD) could be worth
$3,102.24
+$2,102.24 (+210%) by 2050 · US Dollar
Based on the average projected AEMD price of $2.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AEMDwould be worth at today's price.
$1,000 invested in AEMD on Jul 31, 2025 (≈ 84.033616 AEMD) would be worth
$56.03
-$943.97 (-94.4%) today · 0.06× · US Dollar
Based on a AEMD entry price of $11.9 vs. today's $0.6668.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.58 | $1,149.66 | +15.0% |
| 1 month ago | $0.76 | $877.37 | -12.3% |
| 3 months ago | $2.3 | $289.91 | -71.0% |
| 6 months ago | $2.4 | $277.83 | -72.2% |
| 1 year ago | $11.9 | $56.03 | -94.4% |
| All time (5.0y) ago | $4,240 | $0.16 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AEMD forecast.
Our base-case forecast reaches $1.30 around 2050.
Implied market cap at $1.30: $3.42M
The multi‑year forecast shows a path with both neutral and bullish periods, including several notable upside years. In 2027 the avg is $0.812 with a max of $1.20 and a min of $0.5915, representing a 22.5% ROI and a bullish sentiment. Earlier, 2032 reports an avg of $0.8282 with a max of $1.53 and a min of $0.4708, yielding a 24.9% ROI and bullish sentiment, underscoring a shift toward higher price expectations in that interval.
The 2033 forecast shows an avg $0.9745, a max $1.85, and a min $0.532, with a 47% ROI and bullish sentiment, while 2034 projects an avg $0.8787, a max $1.71, and a min $0.4611, delivering a 32.6% ROI and bullish stance. The 2030 figure sits at an avg of $0.661 with a min of $0.4098, a max of $1.14, and a −0.3% ROI, remaining neutral in sentiment.
By 2040 the forecast rises to an avg of $1.15, a min of $0.5174, a max of $2.52, and a 73.5% ROI with bullish sentiment, while 2050 shows an avg of $2.06, a min of $0.9256, a max of $4.73, and a 210.3% ROI with bullish sentiment. These numbers illustrate a broad potential upside over the long horizon, tempered by periods of lower or negative returns in earlier years.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $0.661, with a min of $0.4098 and a max of $1.14, and a −0.3% ROI. The sentiment is NEUTRAL.
Forecasts show a mix of outcomes over the period, including a bullish year in 2027 with ROI 22.5% and bullish years in 2032 (ROI 24.9%), 2033 (ROI 47%), 2034 (ROI 32.6%), and 2040 (ROI 73.5%), alongside neutral or negative years such as 2029 (ROI -7.3%) and 2030 (ROI -0.3%). These are estimates, not guarantees, and should be considered within a broader investment context.
Yes. The 2027 forecast lists a max of $1.20 and an avg of $0.812, indicating that $1.00 could be reached within that year’s projection.
RSI(14) is 40 with sentiment NEUTRAL. The SMA50 is $1.34 and the SMA200 is $2.56. Support is at $0.53 and resistance at $1.89. The 30‑day price range is $0.439 to $1.00.
The 2050 forecast shows a min of $0.9256, an avg of $2.06, and a max of $4.73 with a 210.3% ROI and bullish sentiment.
Aethlon Medical, Inc. Community Discussion
0Share your Aethlon Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.